Seneca Biopharma, Stonebridge Biopharma and Sundial Growers Pre Market

Shares of Seneca Biopharma (NASDAQ:SNCA) are very active pre-market following their run Friday. While $SNCA stock closed at $1.64 during the regular session, shares climbed as high as $1.93 before the final bell rang after hours.

Strongbridge Biopharma (NASDAQ:SBBP) is also trading higher after announcing detailed results from the previously reported Phase 3 LOGICS study of RECORLEV ® (levoketoconazole) in patients with endogenous Cushing’s syndrome. Detailed results of the study reported that LOGICS met its primary endpoint with statistical significance. Also, the key secondary endpoint of mUFC normalization at the end of the RW phase was also statistically significant with 45.5 percent more patients treated with RECORLEV maintaining mUFC normalization in the active arm than the placebo arm (p = 0.0015).
On March 2, 2021, the Company announced it had submitted an NDA for RECORLEV for the treatment of endogenous Cushing’s syndrome to the FDA. 

Also very actively trading Monday are : RLX Technology Inc (NYSE:RLX), Hall of Fame Resort & Entertainment (NASDAQ:HOFV), TapImmune Inc. (NASDAQ:MRKR), Cemtrex Inc. (NASDAQ:CETX) and Sundial Growers (NASDAQ:SNDL), who last week revealed they are actively pursuing Merger and Acquisitions activities.